Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin HIPEC flushing pharmacology study
NL-OMON46544Completed
- Sponsor
- Ziekenhuisapotheek
- Start
- Apr 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxaliplatin in peritoneal carcinomatosis (PC) (2 arms), sponsored by Ziekenhuisapotheek. Primary endpoint: Change in tissue platinum exposure before and after flushing. Started Apr 2018; status: completed.
02
Drugs
oxaliplatin
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NL-OMON46544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46544.